Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

Researchers from New England Biolabs and Yale University have created a system for engineering the first fully synthetic bacteriophages that could help with future clinical development of phage ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...

OpenAI chief executive Sam Altman and his husband Oliver Mulherin have backed a controversial startup investing in genetically engineering babies to eliminate hereditary diseases. The company, called ...